SIG
70
-2
MET
50
3
OKE
59
3
AAPL
71
10
LRCX
59
6
HPQ
67
4
SYY
53
3
AFL
57
-5
IVZ
43
5
AEP
56
3
QCOM
82
2
RIG
44
3
UAL
56
2
BSX
71
2
NWS
79
15
EQT
57
3
PNC
52
3
YUM
56
2
MMM
32
2
NTRS
35
5
SIG
70
-2
MET
50
3
OKE
59
3
AAPL
71
10
LRCX
59
6
HPQ
67
4
SYY
53
3
AFL
57
-5
IVZ
43
5
AEP
56
3
QCOM
82
2
RIG
44
3
UAL
56
2
BSX
71
2
NWS
79
15
EQT
57
3
PNC
52
3
YUM
56
2
MMM
32
2
NTRS
35
5
Financhill
Back

Inovio Pharmaceuticals 10K Form

Buy
53

INO
Inovio Pharmaceuticals

Last Price:
12.12
Seasonality Move:
12.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INO News And Ratings

See the #1 stock for the next 7 days that we like better than INO

INO Financial Statistics

Sales & Book Value

Annual Sales: $832.01K
Cash Flow: $-26.28M
Price / Cash Flow: 0
Annual Sales: $5.15
Price / Book: 2.41

Profitability

EPS (TTM): -6.09000
Net Income (TTM): $-135.12M
Gross Margin: $0
Return on Equity: -79.81%
Return on Assets: -55.73%

Inovio Pharmaceuticals Earnings Forecast

Key Inovio Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for INO is 0.00%.
  • The Selling, General & Administrative Expenses for INO have been equal to 5,718.93% of Gross Profit Margin.
  • The Research & Development expenses have been 10,417.73% of Revenue.
  • The Interest Expense is -0.90% of Operating Income.
  • The Net Earning history of INO is -16,239.87% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Inovio Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INO
CUSIP: 45773H
Website: inovio.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 3.6
Quick Ratio: 3.47

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INO Technical Analysis vs Fundamental Analysis

Buy
53
Inovio Pharmaceuticals (INO) is a Buy

Is Inovio Pharmaceuticals a Buy or a Sell?